Location: Home
  • search
  • go
  • Relate News
  • 6/7/2010Jiangbo Pharma to be listed on NASDAQ
  • 6/7/2010Guangdong to issue new drug price control regulation
  • 6/7/2010Nanjing Pharma to boost investments in its pharmacy service subsidiary...
  • 6/7/2010Bayer's Gadovist approved in China
  • 6/6/2010Amgen eyes deals in emerging markets
  • 6/5/2010Rumor: Deputy SFDA Commissioner under house arrest and investigations ...
  • 6/5/2010MOH and Bayer jointly promotes standardized therapy for primary hepati...
  • 6/5/2010SFDA approves new anti-depressant of SIPI and Shanghai Modern
  • 6/5/2010Pharma industry leads other sectors for layoffs in the U.S.
  • 6/3/2010Asymchem Labs appoints senior research executive
  • 6/3/2010China to issue new GMP with three year transitional period
  • 6/3/2010Leading Chinese oncology players turn to diabetes market for more grow...
  • 6/2/2010The State Council eyes the "Minhang Model" of hospital drug ...
  • 6/2/2010New study claims 60% hospital rebates in essential drug sales even at ...
  • 6/2/2010Mainland China and Hong Kong signs regulatory cooperation agreement
  • 6/1/2010Clearstone appoints new BD head for China
  • 6/1/2010CPIA: Hospital drug purchase of top 100 suppliers rose 23% in 2009
  • 6/1/2010Pharma China co-founds healthcare communications service in China
  • 6/1/2010Lizhu and Joincare forms JV for monoclonal antibody drugs
  • 6/1/2010New steroid API manufacturing facility begins operation in Shaanxi
  • 5/31/2010SIPI: China's hospital drug market growth slows in 2009
  • 5/31/2010Kelun Pharma's IPO may be suspended again
  • 5/28/2010MOH outlines cost containment measures for drug expenditures
  • 5/28/2010MSD China: pricing flexibilities for expanded market?
  • 5/28/2010NH: Global OTC drug market grew 4.6% despite economic woes
  • 5/28/2010NH: Chinese OTC dermatological sales up 9% in 2009
  • 5/28/2010Pfizer sells Chinese swine-vaccine business to Harbin Pharma
  • 5/28/2010HUYA Bioscience enters strategic partnership with TCM university
  • 5/28/2010Is the NDRC Bluffing or Signaling A New Round of Price Cuts?
  • 5/28/2010IMS: China is home to an especially strong oncology market
  • Page:560/719 Total number of articles:21559: [First][<<] [558] [559] [560] [561] [562] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group